SEC reporting owner
| Reporting owner CIK | 0001618442 |
|---|---|
| Issuers | 37 |
| Qualifying disclosures | 151 |
| Public purchases | 127 |
| Recent-window purchases | 1 |
| Recent-window sales | 10 |
| Last public filing | 2026-08-11 |
| Coverage | verified |
| Directory rank | 19,348 |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-08-10 | 2026-08-10 | BLSM | P | 312,500 | Not reported |
| 2026-08-10 | 2026-08-06 | BLSM | A | 23,904 | Not reported |
| 2026-04-30 | 2026-04-28 | DRUG | S | 109,331 | Not reported |
| 2025-12-15 | 2025-12-11 | CRBP | S | 30,029 | Not reported |
| 2025-12-08 | 2025-12-04 | EYPT | S | 60,000 | Not reported |
| 2025-10-01 | 2025-09-30 | MLTX | S | 5,827 | Not reported |
| 2025-10-01 | 2025-09-29 | MLTX | S | 2,800,000 | Not reported |
| 2025-10-01 | 2025-09-29 | MLTX | S | 3,390,943 | Not reported |
| 2025-10-01 | 2025-09-29 | MLTX | S | 232,460 | Not reported |
| 2025-10-01 | 2025-09-29 | MLTX | S | 70,748 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.